Home ETF List About

ETF Holdings Breakdown of ACLX

Stock NameArcellx Inc
TickerACLX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03940C1009

ACLX institutional holdings

The adjusted close for ACLX on 2025-11-12 was 90.14

The following institutional investment holdings of ACLX have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 20,766USD 1,871,951 -0.1% 90.14  
2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 7,987 -0.3%USD 719,988 -0.4% 90.14  
2025-11-12 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 50,562USD 4,557,911 90.14  
2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 36,051USD 3,249,817 90.14  
2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 36,051 0.3%USD 3,249,817 0.2% 90.14  
2025-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 210USD 18,930 -0.1% 90.14  
Total =151,627 USD 13,668,414
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ACLX

Arcellx, Inc. (NASDAQ:ACLX) Receives $114.31 Consensus Target Price from Analysts
Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have been given an average recommendation of “Buy” by the fifteen research firms that are covering the firm, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month […] - 2025-08-20 02:08:54
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Deutsche Bank AG
Deutsche Bank AG lowered its position in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 0.2% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 343,694 shares of the company’s stock after selling 835 shares during the quarter. Deutsche Bank AG’s holdings in Arcellx were worth $22,546,000 as of its most recent SEC filing. A […] - 2025-08-14 04:59:07
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank lowered its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 2.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,579 shares of the company’s stock after selling 257 shares during the […] - 2025-08-07 05:16:57
Victory Capital Management Inc. Cuts Position in Arcellx, Inc. (NASDAQ:ACLX)
Victory Capital Management Inc. lowered its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 3.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 178,110 shares of the company’s stock after selling 6,073 shares during the quarter. Victory Capital Management Inc.’s holdings in […] - 2025-07-24 05:04:49
Bank of New York Mellon Corp Lowers Position in Arcellx, Inc. (NASDAQ:ACLX)
Bank of New York Mellon Corp lowered its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 143,617 shares of the company’s stock after selling 792 shares during the period. Bank […] - 2025-07-22 07:29:04
Allspring Global Investments Holdings LLC Grows Holdings in Arcellx, Inc. (NASDAQ:ACLX)
Allspring Global Investments Holdings LLC raised its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 54.0% during the first quarter, Holdings Channel reports. The fund owned 7,702 shares of the company’s stock after buying an additional 2,702 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Arcellx were worth $468,000 as of […] - 2025-07-11 04:38:48
Arcellx (NASDAQ:ACLX) Coverage Initiated at Citigroup
Citigroup started coverage on shares of Arcellx (NASDAQ:ACLX – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $110.00 price target on the stock. Citigroup’s price target suggests a potential upside of 72.36% from the company’s previous close. A number of other brokerages have also […] - 2025-06-19 02:26:48
Harbor Capital Advisors Inc. Sells 629 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Harbor Capital Advisors Inc. lessened its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 22,836 shares of the company’s stock after selling 629 shares during the period. Harbor Capital Advisors Inc.’s holdings in Arcellx were […] - 2025-06-13 05:16:51
Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Squarepoint Ops LLC cut its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 46.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,330 shares of the company’s stock after selling 4,670 shares during the period. Squarepoint Ops LLC’s holdings […] - 2025-06-06 05:14:57
Arcellx, Inc. (NASDAQ:ACLX) Receives $111.33 Average Target Price from Analysts
Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are currently covering the stock, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year […] - 2025-06-06 02:04:54
Two Sigma Advisers LP Purchases 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Two Sigma Advisers LP grew its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 24.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,600 shares of the company’s stock after buying an additional 1,100 shares during the period. Two Sigma Advisers LP’s holdings in Arcellx were worth $429,000 as of […] - 2025-06-05 05:14:49
Millennium Management LLC Boosts Holdings in Arcellx, Inc. (NASDAQ:ACLX)
Millennium Management LLC lifted its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 123.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,370 shares of the company’s stock after purchasing an additional 12,370 shares during the quarter. Millennium […] - 2025-06-03 05:04:53
Nuveen Asset Management LLC Has $8.57 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)
Nuveen Asset Management LLC lowered its position in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,786 shares of the company’s stock after selling 9,110 shares during the period. Nuveen […] - 2025-05-29 04:54:51
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.10 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 6.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,363 shares of the company’s stock after purchasing an additional 1,589 shares during the quarter. MIRAE […] - 2025-05-22 05:51:03
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) Price Target at $109.31
Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have earned an average recommendation of “Buy” from the fifteen ratings firms that are presently covering the company, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year target […] - 2025-05-12 02:24:57
Dimensional Fund Advisors LP Acquires 186,013 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Dimensional Fund Advisors LP lifted its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 156.2% in the fourth quarter, Holdings Channel reports. The fund owned 305,088 shares of the company’s stock after purchasing an additional 186,013 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Arcellx were worth $23,400,000 at the end of […] - 2025-05-07 05:22:53
Mariner LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX)
Mariner LLC grew its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 37.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,980 shares of the company’s stock after purchasing an additional 1,915 shares during the period. Mariner LLC’s holdings […] - 2025-05-02 05:08:50
Invesco Ltd. Boosts Stake in Arcellx, Inc. (NASDAQ:ACLX)
Invesco Ltd. boosted its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 15.7% in the 4th quarter, Holdings Channel reports. The firm owned 26,550 shares of the company’s stock after purchasing an additional 3,610 shares during the period. Invesco Ltd.’s holdings in Arcellx were worth $2,036,000 at the end of the most recent quarter. […] - 2025-04-30 04:44:58
Renaissance Technologies LLC Takes $3.77 Million Position in Arcellx, Inc. (NASDAQ:ACLX)
Renaissance Technologies LLC bought a new stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 49,100 shares of the company’s stock, valued at approximately $3,765,000. Renaissance Technologies LLC owned approximately 0.09% of Arcellx at […] - 2025-04-23 05:27:02
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Legal & General Group Plc
Legal & General Group Plc reduced its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 3.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 43,033 shares of the company’s stock after selling 1,402 shares during the period. Legal & General Group Plc’s holdings in Arcellx were worth $3,300,000 as of […] - 2025-04-23 05:26:58
Wellington Management Group LLP Sells 1,275 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Wellington Management Group LLP reduced its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,693 shares of the company’s stock after selling 1,275 shares during the period. Wellington Management […] - 2025-04-14 04:44:59
Trexquant Investment LP Purchases Shares of 7,237 Arcellx, Inc. (NASDAQ:ACLX)
Trexquant Investment LP acquired a new position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,237 shares of the company’s stock, valued at approximately $555,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-13 06:00:57
Pictet Asset Management Holding SA Purchases 1,426 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Pictet Asset Management Holding SA grew its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 40.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,945 shares of the company’s stock after buying an additional 1,426 shares during the period. Pictet Asset Management […] - 2025-04-10 05:37:03
Arcellx (NASDAQ:ACLX) Stock Price Down 6.8% After Insider Selling
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) traded down 6.8% during trading on Wednesday following insider selling activity. The company traded as low as $49.55 and last traded at $49.95. 248,582 shares changed hands during trading, a decline of 63% from the average session volume of 668,721 shares. The stock had previously closed at $53.60. […] - 2025-04-10 02:40:50
Arcellx, Inc. (NASDAQ:ACLX) Stock Holdings Lessened by Corebridge Financial Inc.
Corebridge Financial Inc. cut its stake in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,430 shares of the company’s stock after selling 1,617 shares during the quarter. Corebridge […] - 2025-04-03 04:34:47
Thrivent Financial for Lutherans Has $5.33 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX)
Thrivent Financial for Lutherans increased its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 44.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 69,461 shares of the company’s stock after purchasing an additional 21,221 shares during the period. Thrivent Financial for Lutherans’ holdings in Arcellx were worth $5,327,000 as […] - 2025-03-25 07:08:51
Victory Capital Management Inc. Sells 43,236 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Victory Capital Management Inc. trimmed its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 184,183 shares of the company’s stock after selling 43,236 shares during the period. Victory Capital Management Inc.’s holdings in Arcellx were worth $14,125,000 at the end of the most […] - 2025-03-13 06:32:53
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) PT at $105.93
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target […] - 2025-02-27 04:22:50
Contrasting Arcellx (NASDAQ:ACLX) and C4 Therapeutics (NASDAQ:CCCC)
C4 Therapeutics (NASDAQ:CCCC – Get Free Report) and Arcellx (NASDAQ:ACLX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Volatility & Risk C4 Therapeutics has a beta of […] - 2025-02-05 04:06:45

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.